| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.42 | 0.02 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.42 | 0.02 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.41 | 0.02 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.34 | 0.03 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.27 | 0.09 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.19 | 0.2 |